Market Access World Asia 2012
27 - 30 November 2012,
TBC, Singapore
Providing value-driven pharmaceuticals in healthcare
The world's most comprehensive policy review forum
Experts in market access, pricing and health policy will provide delegates with a comprehensive review of the local payer expectations and information/evidence on how to develop a stronger and more effective market access strategy in Asia.
You will hear a balanced discussion between industry and public, private sector payers
Come to Market Access World Asia 2012
Receive expert advice on how to:
- plan a market access strategy that will ensure the best price and reimbursement strategy and patient population
- guarantee a good ROI for drugs
- understand the evolving healthcare environment across Asia-Pacific and the resulting market access opportunities and challenges for pharma
- communicate the value of your product to relevant stakeholders in Asia
- gain competitive advantage with a deep dive into key countries of interest including China, Japan, South Korea, Thailand, Taiwan and India
- review of the key self-pay markets
- latest update on the HTA environment and the possible emergence of HTA in Japan
Who should attend
- Health Policy
- Market Access
- Pricing & Reimbursement
- Health Economics/Outcomes
- HTA/Comparative Effectiveness
- Evidence Based Medicine
- Pharmacoeconomics
- Chief Pharmacy Officers
- Chief Medical Officers
- Marketing
- Medical Affairs
- Government, Payer & Stakeholder relation
World class solution providers attend to
- Position their products and services in front of decision makers from major pharma and biotech companies
- Meet and do business with senior execs within the pharmaceutical market access and pricing reimbursement community
- Position themselves as a thought leader
- Generate leads and new business
Who should sponsor
- CRO’s
- Niche CRO’s
- IT/Software/Data Providers
- Consultants
- Communications
- Legal
